154 related articles for article (PubMed ID: 8721508)
1. Discoloration of the nail plate due to the misuse of amorolfine 5% nail lacquer.
Rigopoulos D; Katsambas A; Antoniou C; Christofidou E; Balaskas E; Stratigos J
Acta Derm Venereol; 1996 Jan; 76(1):83-4. PubMed ID: 8721508
[No Abstract] [Full Text] [Related]
2. A pilot, layerwise, ex vivo evaluation of the antifungal efficacy of amorolfine 5% nail lacquer vs other topical antifungal nail formulations in healthy toenails.
Ghannoum M; Long L; Kunze G; Sarkany M; Osman-Ponchet H
Mycoses; 2019 Jun; 62(6):494-501. PubMed ID: 30667544
[TBL] [Abstract][Full Text] [Related]
3. A randomized comparison of nail surface remanence of three nail lacquers, containing amorolfine 5%, ciclopirox 8% or tioconazole 28%, in healthy volunteers.
Sidou F; Soto P
Int J Tissue React; 2004; 26(1-2):17-24. PubMed ID: 15573688
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy and safety of amorolfine nail lacquer 2% versus 5% once weekly.
Lauharanta J
Clin Exp Dermatol; 1992 Sep; 17 Suppl 1():41-3. PubMed ID: 1458664
[TBL] [Abstract][Full Text] [Related]
5. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective.
Elsayed MM
J Control Release; 2015 Feb; 199():132-44. PubMed ID: 25481439
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy for onychomycosis using a fractional 2940-nm Er:YAG laser and 5 % amorolfine lacquer.
Zhang J; Lu S; Huang H; Li X; Cai W; Ma J; Xi L
Lasers Med Sci; 2016 Sep; 31(7):1391-6. PubMed ID: 27339057
[TBL] [Abstract][Full Text] [Related]
7. An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates.
McAuley WJ; Jones SA; Traynor MJ; Guesné S; Murdan S; Brown MB
Eur J Pharm Biopharm; 2016 May; 102():178-84. PubMed ID: 26969264
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of 5% amorolfine nail lacquer in Neoscytalidium dimidiatum onychomycosis.
Bunyaratavej S; Leeyaphan C; Rujitharanawong C; Surawan TM; Muanprasat C; Matthapan L
J Dermatolog Treat; 2016 Aug; 27(4):359-63. PubMed ID: 26471716
[TBL] [Abstract][Full Text] [Related]
9. Application of cosmetic nail varnish does not affect the antifungal efficacy of amorolfine 5% nail lacquer in the treatment of distal subungual toenail onychomycosis: results of a randomised active-controlled study and in vitro assays.
Sigurgeirsson B; Ghannoum MA; Osman-Ponchet H; Kerrouche N; Sidou F
Mycoses; 2016 May; 59(5):319-26. PubMed ID: 26867498
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and tolerability of amorolfine 5% nail lacquer in combination with systemic antifungal agents for onychomycosis: A meta-analysis and systematic review.
Feng X; Xiong X; Ran Y
Dermatol Ther; 2017 May; 30(3):. PubMed ID: 28097731
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Antifungal Activity and Nail Penetration of ME1111, a New Antifungal Agent for Topical Treatment of Onychomycosis.
Tabata Y; Takei-Masuda N; Kubota N; Takahata S; Ohyama M; Kaneda K; Iida M; Maebashi K
Antimicrob Agents Chemother; 2016 Feb; 60(2):1035-9. PubMed ID: 26643333
[TBL] [Abstract][Full Text] [Related]
12. Absorption of amorolfine through human nail.
Franz TJ
Dermatology; 1992; 184 Suppl 1():18-20. PubMed ID: 1550966
[TBL] [Abstract][Full Text] [Related]
13. Onychomycosis in a very young child.
Zac RI; Café ME; Neves DR; E Oliveira PJ; Barbosa VG
Pediatr Dermatol; 2009; 26(6):761-2. PubMed ID: 20199466
[TBL] [Abstract][Full Text] [Related]
14. Topical treatment approved for fungal nail infection.
Miller JL
Am J Health Syst Pharm; 2000 Feb; 57(3):205. PubMed ID: 10674767
[No Abstract] [Full Text] [Related]
15. Determination of the subungual antifungal activity of amorolfine after 1 month's treatment in patients with onychomycosis: comparison of two nail lacquer formulations.
Mensing H; Polak-Wyss A; Splanemann V
Clin Exp Dermatol; 1992 Sep; 17 Suppl 1():29-32. PubMed ID: 1458661
[No Abstract] [Full Text] [Related]
16. Patient-reported outcomes from two randomised studies comparing once-weekly application of amorolfine 5% nail lacquer to other methods of topical treatment in distal and lateral subungual onychomycosis.
Schaller M; Sigurgeirsson B; Sarkany M
Mycoses; 2017 Dec; 60(12):800-807. PubMed ID: 28925059
[TBL] [Abstract][Full Text] [Related]
17. An unusual clinical presentation of tinea faciei caused by Trichophyton mentagrophytes var. erinacei.
Lee DW; Yang JH; Choi SJ; Won CH; Chang SE; Lee MW; Choi JH; Moon KC; Kim MN
Pediatr Dermatol; 2011; 28(2):210-2. PubMed ID: 21504458
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility testing of amorolfine, bifonazole and ciclopiroxolamine against Trichophyton rubrum in an in vitro model of dermatophyte nail infection.
Schaller M; Borelli C; Berger U; Walker B; Schmidt S; Weindl G; Jäckel A
Med Mycol; 2009 Nov; 47(7):753-8. PubMed ID: 19888808
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the nail penetration of antifungal agents, with different physico-chemical properties.
Davies-Strickleton H; Cook J; Hannam S; Bennett R; Gibbs A; Edwards D; Ridden C; Ridden J; Cook D
PLoS One; 2020; 15(2):e0229414. PubMed ID: 32107486
[TBL] [Abstract][Full Text] [Related]
20. Experimental tinea unguium model to assess topical antifungal agents using the infected human nail with dermatophyte in vitro.
Nakashima T; Nozawa A; Ito T; Majima T
J Infect Chemother; 2002 Dec; 8(4):331-5. PubMed ID: 12525893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
